Mometasone Cream (ACP) – Labeling Error (2019)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37
Brand
ACP Nimble Buyer, Inc.
Lot Codes / Batch Numbers
Lot #: 1009431, 1009507, Exp. 08/2020, 1009886, Exp. 09/2020
Products Sold
Lot #: 1009431, 1009507, Exp. 08/2020; 1009886, Exp. 09/2020
ACP Nimble Buyer, Inc. is recalling Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Pl due to Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026